This is a preview of subscription content, log in via an institution to check access.
Literatur
Gross GE et al. S3-Leitlinie Impfprävention HPV-assoziierter Neoplasien 2020. AWMF-Registernr. 082-002
Robert Koch-Institut (Hrsg.). Epidemiologisches Bulletin 2007;12:97-103
Drolet M et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 2019;394:497-509
Kjaer SK et al. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer. J Natl Cancer Inst 2021;113:1329-35
Lei J et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020;383:1340-8
Kamolratanakul S et al. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines 2021;9:1413
Deutsches Krebsforschungszentrum (Hrsg.). Memorandum anlässlich des 3. Runden Tisches zur Eliminierung HPV-assoziierter Krebserkrankungen in Deutschland am 29.09.2021. https://go.sn.pub/6k1KCq (letzter Aufruf: 18.8.2022)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, F. HPV und Krebsprävention. hautnah dermatologie 38, 75–77 (2022). https://doi.org/10.1007/s15012-022-7513-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15012-022-7513-7